INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we hereby submit Annual Secretarial Compliance Report from a practicing Company Secretary, for the year ended 31st March, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2020
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Management
This is to inform that the Board of Directors of the Company has, at its meeting held on Saturday, 23rd May, 2020 (i.e. today), inter-alia, considered and approved the following items: Re-appointed Dr. Arun Rai (DIN : 07159822 ) as Independent Director of the Company, for a period of 5 consecutive years effective from 26th May, 2020 to 25th May, 2025, subject to the approval of the shareholders of the Company. Appointed Dr. Menaka Guruswamy (DIN : 0008742679) as Independent Woman Director of the Company, for a period of 5 consecutive years effective from 23rd May, 2020 to 22nd May, 2025, subject to the approval of the shareholders of the Company. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Results For The Quarter And Year Ended 31St March, 2020
This is to inform that the Board of Directors of the Company has, at its meeting held on Saturday, 23rd May, 2020 (i.e. today), inter-alia, considered and approved :- (a) Audited Financial Results for the quarter and financial year ended 31st March, 2020, along with a copy of the Audit Report by the Statutory Auditors of the Company; (b) A declaration by CFO confirming that the Auditors have given an Unmodified Opinion on the Annual Audited Financial Results of the Company for the financial year ended 31st March 2020, as required under second proviso to regulation 33(3)(d) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015; INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Audited Financial Results For The Quarter / Year Ended 31St March, 2020
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Saturday, 23rd May, 2020, inter alia to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Quarter Ended 31St March, 2020
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the half year ended 31st March, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended March 31, 2020
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that the Company has followed adequate procedure for transfer/dematerialisation of shares and has defaced and cancelled all the certificates for dematerialised shares for the quarter ended 31st March, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Certificate For The Half Year Ended 31St March, 2020
Pursuant to Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the half year ended 31st March, 2020, within 30 days of the date of lodgment for transfer, This is for your information and record.